**Core Concept**
The question is testing knowledge of tumor suppressor genes involved in endometrial carcinoma, a common type of cancer affecting the uterus. The correct answer is related to the genetic mechanism underlying this disease.

**Why the Correct Answer is Right**
Endometrial carcinoma is often associated with mutations in the PTEN gene, a tumor suppressor gene that plays a critical role in regulating cell growth and division. PTEN gene mutations lead to the loss of its phosphatase activity, resulting in the activation of the PI3K/AKT signaling pathway, which promotes cell proliferation and survival. This contributes to the development and progression of endometrial cancer.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not mention the correct tumor suppressor gene associated with endometrial carcinoma.
* **Option B:** This option is incorrect because it is not directly related to endometrial carcinoma, although it may be relevant to other types of cancer.
* **Option C:** This option is incorrect because it is not a tumor suppressor gene, but rather a gene involved in cell cycle regulation.

**Clinical Pearl / High-Yield Fact**
The PTEN gene is a key tumor suppressor gene in endometrial cancer, and its mutations are associated with increased risk and poorer prognosis. Understanding the genetic mechanisms underlying this disease is crucial for developing effective treatments.

**Correct Answer: PTEN**